प्रीमियम लेवल पर ब्रेकआउट: क्या PVRINOX में तेजी की रफ्तार बरकरार रहेगी?

by

Technical Chart Analysis

  • PVRINOX showed a strong move, closing at 1127.30 after opening at 1095 and hitting a high of 1133.5. The long green candle with high volume signals renewed bullish momentum.

  • Price reclaimed all major near-term moving averages (14/20/50 EMA/SMA) and broke out above recent resistance.

  • RSI(14): 55.7, trending upwards; bullish but not yet overbought.

  • MACD: Bullish crossover is active; momentum surge confirmed.

  • Parabolic SAR: Dots shifted below candles—clear reversal signal.

  • Immediate resistance is at 1135–1145, support at 1090–1080.


Fundamental View & Figures (Q2 FY25/latest)

  • Market Cap: ₹11,082 crore.

  • Intrinsic Value: Estimated ₹1,935.98 vs current price ~₹1,127, trading at ~42% discount, indicating attractive value zone.

  • P/E (TTM): Negative, as company has faced losses due to post-pandemic impacts and high operating costs.

  • P/B Ratio: 1.54x, healthy for sector.

  • Sales (TTM): ₹6,058 crore; EBITDA margin: ~31% (recent contraction due to slower footfalls).

  • PAT (Q2 FY25): Loss of ₹12 crore (Q2); loss narrowed vs last year. Revenue fell 19% YoY to ₹1,622 crore.

  • Admits (Q2): 38.8 million vs 69.2 million H1; ATP: ₹257, SPH: ₹136.

  • Total Screens: 1,747 screens, 356 cinemas, India’s largest multiplex chain.

  • Debt Status: Net debt reduced by ₹1,409 crore to ₹12,940 crore since March 2024.


Why Did the Stock Move So Much?

  • Technical breakout above major moving averages after weeks of consolidation.

  • Strong Q2 recovery signals from cinema/screen earnings; revenue and profit loss narrowed, showing improved operational control.

  • Surge in festive footfalls and popular film releases drove optimism.

  • New screens opened, ATP and SPH indicators improved, suggesting higher monetization.


News, Event Flow & Impact

  • CCI Investigation:
    Competition Commission of India (CCI) has initiated a probe into PVRINOX’s virtual print fee (VPF) practices, after complaints of unfair charges harming producers.

    • Investigation outcome could affect future fee structure, but not immediate footfall or ticket revenue.

  • Quarterly Results:
    Q2 FY25 in focus—losses narrowed; revenue contraction due to slower film slate in September, but festive/Diwali releases expected to boost Q3 volumes.

  • Upcoming Trend:
    Increased number of movie releases, promotions, and festivals (Diwali, Christmas) could lead to higher admission and top-line growth in the next quarter.


Buy Levels & View

  • Is it buyable?
    Yes, dips toward 1100–1110 (closer to 20/50 EMA) can be considered for accumulation with stoploss at 1080. If the stock sustains above 1135, next short-term targets are 1165–1190.

  • Short-Term:
    Bullish reversal confirmed above moving averages, momentum likely to sustain if volume remains high.

  • Long-Term:
    Structural positives—India’s largest screen/networks, post-pandemic footfall rebound, cost management—suggest value for long-term investors, though regulatory investigation and quarterly losses require moderate allocation and review.


Disclaimer & Disclosure

This analysis is meant for informational purposes only, not investment advice. All data are based on market filings and public releases; accuracy can’t be guaranteed. Consult a financial advisor before making decisions. All investing involves capital risk; views are personal research and must not be redistributed without permission.Daily Chart Analysis on PVRINOX at 04102025